title: microRNA-17~92 is a powerful cancer driver and a therapeutic target.
authors.affiliation: Department of Immunology and Microbial Science; The Scripps Research Institute; La Jolla, CA USA; Kellogg School of Science and Technology; The Scripps Research Institute; La Jolla, CA USA.
authors.forename: Hyun Yong
authors.initials: HY
authors.lastname: Jin
authors.affiliation: Department of Immunology and Microbial Science; The Scripps Research Institute; La Jolla, CA USA.
authors.forename: Maoyi
authors.initials: M
authors.lastname: Lai
authors.affiliation: Department of Immunology and Microbial Science; The Scripps Research Institute; La Jolla, CA USA.
authors.forename: Changchun
authors.initials: C
authors.lastname: Xiao
mesh_terms: D000818:Animals; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008223:Lymphoma / Q000235:genetics*; D035683:MicroRNAs / Q000502:physiology*
chemical_list: D035683:MicroRNAs
keywords: MicroRNA; NFκB; PI3K; cancer; lymphoma; miR-17~92; therapeutics